288 related articles for article (PubMed ID: 1098475)
1. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.
Busch GJ; Kobayashi K; Hollenberg NK; Birtch AG; Colman RW
Am J Pathol; 1975 Jul; 80(1):1-20. PubMed ID: 1098475
[TBL] [Abstract][Full Text] [Related]
2. A primate model of hyperacute renal allograft rejection.
Busch GJ; Martins AC; Hollenberg NK; Wilson RE; Colman RW
Am J Pathol; 1975 Apr; 79(1):31-56. PubMed ID: 1092189
[TBL] [Abstract][Full Text] [Related]
3. Successful short-term modification of hyperacute renal allograft rejection in the primate. Intrarenal effects of phenoxybenzamine and methylprednisolone combined with heparin.
Busch GJ; Martins AC; Hollenberg NK; Moretz RC; Wilson RE; Colman RW
Am J Pathol; 1976 Jan; 82(1):43-60. PubMed ID: 813526
[TBL] [Abstract][Full Text] [Related]
4. Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin.
Colman RW; Habal M; Hollenberg NK; Birtch AG; Busch GJ
Am J Pathol; 1976 Jan; 82(1):25-42. PubMed ID: 813525
[TBL] [Abstract][Full Text] [Related]
5. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
Ito S; Camussi G; Tetta C; Milgrom F; Andres G
Lab Invest; 1984 Aug; 51(2):148-61. PubMed ID: 6379289
[TBL] [Abstract][Full Text] [Related]
6. [Hyperacute rejection of an HL-A identical renal allograft (author's transl)].
Wiedermann G; Stemberger H; Ambrosch F; Tappeiner G; Schadlbauer B; Kux M
Wien Klin Wochenschr; 1977 Jan; 89(1):11-3. PubMed ID: 319603
[TBL] [Abstract][Full Text] [Related]
7. Biopsy features of early acute rejection in cadaveric renal grafts.
Kincaid-Smith P; McKenzie IF; Morris PJ; Marshall VC
Transplant Proc; 1969 Mar; 1(1):287-9. PubMed ID: 4944228
[No Abstract] [Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
9. The effect of anticomplementary cobra venom factor on hyperacute rat cardiac allograft rejection.
Forbes RD; Pinto-Blonde M; Guttmann RD
Lab Invest; 1978 Nov; 39(5):463-70. PubMed ID: 366280
[TBL] [Abstract][Full Text] [Related]
10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of local heparin infusion in a canine renal allograft model.
Gruber SA; Cipolle RJ; Tzardis P; Skjei KL; Jossart G; Abed JF; Canafax DM; Burke BA; Matas AJ; Hrushesky WJ
J Pharmacol Exp Ther; 1990 Feb; 252(2):733-8. PubMed ID: 2313597
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
13. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
Yang H; Chen G; Kanai N; Shum J; Garcia B; Huang X; Min W; Luo Y; Dutartre P; Zhong R
Transplantation; 2003 Apr; 75(8):1166-71. PubMed ID: 12717197
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
16. [Hyperacute kidney graft rejection with and without demonstration of antibodies].
Kux M
Chirurg; 1975 Jun; 46(6):262-7. PubMed ID: 1102270
[TBL] [Abstract][Full Text] [Related]
17. Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients.
Jakobs FM; Davis EA; White T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 Mar; 17(3):306-11. PubMed ID: 9563608
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis: a study of coagulation parameters and mechanisms during allograft rejection.
Mandel SR; Shermer R; Clark R; Staab EV; Webster WP
Thromb Haemost; 1979 May; 41(3):553-66. PubMed ID: 380049
[TBL] [Abstract][Full Text] [Related]
19. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
20. Disseminated intravascular coagulation induced by Liquoid in the rat. II. Effect of heparin on hematologic and complement abnormalities and renal lesions studied by light, fluorescence, and electron microscopy.
Urizar RE; Sherer G; Tartaglia A; Pickering RJ; Dodds WJ
Lab Invest; 1976 May; 34(5):510-5. PubMed ID: 1271752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
